Feedback / Questions
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Adjuvant management of resectable stage III/IV melanoma.
(PubMed, Transl Cancer Res)
-
Oct 15, 2026 -
No abstract available
Journal
•
Melanoma • Oncology • Solid Tumor
http://www.ncbi.nlm.nih.gov/pubmed/42870778
Matthew J Hadfield; Nicole Flores
Oct 15, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next